Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago. 1985

R Shekar, and T W Rice, and C H Zierdt, and C A Kallick

At Cook County Hospital (Chicago), before 1977, the incidence of endocarditis caused by Pseudomonas aeruginosa was one or two cases per year. The frequency of P. aeruginosa as an etiologic agent of endocarditis among drug abusers increased steadily from five (23%) of 22 patients in 1977 to 15 (68%) of 22 in 1980. P. aeruginosa serotype O11 accounted for 34 (76%) of 42 of the strains serotyped. The total increase in incidence of P. aeruginosa endocarditis that we observed can be attributed to disease caused by serotype O11. We serotyped 152 strains of P. aeruginosa obtained from hospital inpatients without endocarditis. Serotype O11 was the most frequently isolated type, accounting for 27% of the total. Incidence of serotype O11 in drug addicts with endocarditis is significantly higher than the incidence in patients with nonendocarditis infections (chi 2 = 32.89; P less than .001). There was a high degree of correlation between pentazocine and tripelennamine ("T's and Blues") abuse and endocarditis caused by P. aeruginosa (chi 2 = 36.71; P less than .001).

UI MeSH Term Description Entries
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002641 Chicago A city in Illinois.
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D014309 Tripelennamine A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically. Azaron,Histantin,Pyribenzamine,Tripelennamine Citrate,Tripelennamine Citrate (1:1),Tripelennamine Hydrochloride,Tripelennamine Maleate,Tripelennamine Maleate (1:1),Tripelennamine Monohydrochloride,Vetibenzamin
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
October 1984, Journal of clinical microbiology,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
February 1985, The Journal of infectious diseases,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
February 2024, Antibiotics (Basel, Switzerland),
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
February 1988, The International journal of the addictions,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
August 1982, Journal of clinical microbiology,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
January 1995, Infection,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
June 1974, Deutsche medizinische Wochenschrift (1946),
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
July 1960, JAMA,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
September 1998, Revista clinica espanola,
R Shekar, and T W Rice, and C H Zierdt, and C A Kallick
September 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!